CD1a-positive dendritic cell-enriched pigmented purpuric dermatosis in association with dyslipidemia
暂无分享,去创建一个
[1] Lisa Mask-Bull,et al. S100-Negative, CD1a-Positive Cutaneous Histiocytosis in a Patient with S100-Positive, CD1a-Positive Pulmonary Histiocytosis. , 2015, The American Journal of dermatopathology.
[2] S. Shalin,et al. Granulomatous pigmented purpuric dermatosis , 2015, Clinical and experimental dermatology.
[3] A. Tall,et al. Cholesterol Efflux Pathways Regulate Myelopoiesis: A Potential Link to Altered Macrophage Function in Atherosclerosis , 2014, Front. Immunol..
[4] Florent Ginhoux,et al. Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny , 2014, Nature Reviews Immunology.
[5] T. D. de Gruijl,et al. IL-10 Conditioning of Human Skin Affects the Distribution of Migratory Dendritic Cell Subsets and Functional T Cell Differentiation , 2013, PloS one.
[6] U. Adamson,et al. Impaired endothelium-dependent skin microvascular function during high-dose atorvastatin treatment in patients with type 1 diabetes , 2013, Diabetes & vascular disease research.
[7] Rachel A. Botting,et al. Identification of Lineage Relationships and Novel Markers of Blood and Skin Human Dendritic Cells , 2013, The Journal of Immunology.
[8] C. Cockerell,et al. Treatment of indeterminate cell histiocytosis with pravastatin. , 2011, Journal of the American Academy of Dermatology.
[9] Michael J. Zilliox,et al. Phenotype, Function, and Gene Expression Profiles of Programmed Death-1hi CD8 T Cells in Healthy Human Adults , 2011, The Journal of Immunology.
[10] M. Cline. Histiocytes and histiocytosis. , 1994, Blood.